Regencell Bioscience Holdings Ltd (RGC): Shareholders' Equity

Annual figures by period end, from SEC filings.

$4.86M
As of 2025-06-30
-34.2%
3-year compound annual growth
$17.07M2019-06-30: -$1.84M2020-06-30: -$2.65M2021-06-30: -$4.00M2022-06-30: $17.07M2023-06-30: $12.03M2024-06-30: $8.22M2025-06-30: $4.86M$4.86M
2019-06-30 Shareholders' Equity (USD) 2025-06-30
Period endedShareholders' EquityChange YoYSource filing
2025-06-30$4.86M-40.9%2025-10-31, Balance as of period end
2024-06-30$8.22M-31.7%2025-10-31, Balance as of period end
2023-06-30$12.03M-29.5%2024-10-25, Balance as of period end
2022-06-30$17.07Mn/m2023-10-27, Balance as of period end
2021-06-30-$4.00Mn/m2022-10-31, Balance as of period end
2020-06-30-$2.65Mn/m2021-10-29, Balance as of period end
2019-06-30-$1.84Mn/a2021-10-29, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Regencell Bioscience Holdings Ltd (RGC)2025-06-30$4.86M-40.9%
Target Group Inc. (CBDY)2025-12-31-$8.06Mn/m
TFA Therapeutics, Inc. (RAJAF)2025-12-31-$534.6Kn/m
Functional Brands Inc. (MEHA)2025-12-31$1.54Mn/m
Synergy CHC Corp. (SNYRQ)2025-12-31-$23.13Mn/m
Charlie's Holdings, Inc. (CHUC)2025-12-31$3.42Mn/m
Cyanotech Corp (CYAN)2025-03-31$8.88M-24.8%
Healthy Extracts Inc. (HYEX)2025-12-31$24.03Mn/m
Mannatech Inc (MTEX)2025-12-31-$5.22Mn/m

Compare RGC, CBDY, RAJAF, MEHA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗